Cytosine methylation at promoter regions and late replication timing have both been implicated in the regulation of genes subject to X chromosome inactivation. Reported here are studies of X-linked gene replication in normal male and female cells as well as in cell hybrids that contain either a normal active X, a normal inactive X, or an inactive X chromosome that has been treated with the demethylating agent, 5-azacytidine (5aC). The relationship between replication timing and transcriptional activity was examined for XIST, XPCT, PGK1, HPRT, F9, FMR1, IDS, and G6PD, and earlier replication was generally found to be associated with increased transcriptional activity. The HPRT and G6PD genes in an untreated inactive X hybrid were among the few exceptions to this correlation in that they remain inactive, yet replicate earlier than their inactive X alleles present in normal human diploid cells. This condition of earlier replication timing may contribute to the high rates of 5aC-induced reactivation for HPRT and G6PD in this hybrid relative to other inactive X hybrids. Other anomalous cases include 5aC-induced advances in replication time for genes such as XIST and F9 whose transcription was unaltered by treatment. These and other data support a model for regulation of X-inactivated genes that involves at least two levels of control: (i) large chromosomal domains are placed into a transcriptionally nonpermissive state by late replication and (ii) transcription is blocked at the local level by promoter methylation. In addition, our observations of continued XIST expression in 5aC-treated hybrids with reactivated genes indicates that such expression is not sufficient for the maintenance of X inactivation.
INTRODUCTION
Attempts to reactivate genes that have been silenced by X chromosome inactivation (1) are nearly as old as the Lyon hypothesis (2). However, consistent reactivation of inactive X-linked genes only became possible when the demethylation agent 5-azacytidine (5aC) was used in somatic cell hybrids by Mohandas et al. (3) . The rationale for using 5aC was based on the suggestion that DNA methylation plays a role in X inactivation and differentiation (4) (5) (6) and the fact that Jones and colleagues had found an induction of cellular differentiation with 5aC treatment of embryonic mouse cells (7) (8) (9) . The initial reactivation finding of Mohandas et al. (3) has been confirmed and extended by a number of studies examining reactivation of X-inactivated genes in either somatic cell hybrids (10) (11) (12) or transformed cells (13, 14) . Such 5aC-induced reactivation occurs with very low frequency in normal rodent cells (14) , however, and is apparently undetectable in normal human cells (15) .
A critical requirement for the reactivation of inactive X-linked housekeeping genes by 5aC is the demethylation of their heavily methylated promoters (16) (17) (18) (19) (20) . The differential reactivation response of normal and transformed cells to 5aC does not appear to involve promoter structure, however, because both cell types have similar patterns of promoter methylation (18, 19, 21) . It follows that a mechanism other than promoter methylation may also be involved in the developmental process resulting in X inactivation. Two-step models of X inactivation have previously been proposed to explain differential reactivation rates in transformed versus normal cells (22) , and in undifferentiated versus differentiated murine embryonal carcinoma cells (23) . In our current replication timing studies of active, inactive, and 5aC-reactivated X-linked genes, we find support for replication timing being a control element involved in X inactivation that can be disturbed in somatic cell hybrids independently of promoter methylation.
Earlier replication timing in expressing tissues versus nonexpressing tissues has been documented for most genes that have been examined, including alpha fetoprotein, serum albumin, T-cell receptor beta chain, beta cluster globin genes, immunoglobulin kappa genes, and immunoglobulin heavy chain genes (24) (25) (26) . In the case of X-linked genes, there is a great deal of cytogenetic evidence that the active X chromosome replicates earlier than the inactive X (27) , and some molecular studies of individual gene replication have been reported (28) (29) (30) (31) (32) (33) . Advanced replication time following 5aC treatment has also been demonstrated cytologically for segments of the inactive X chromosome (34, 35) , and one report of this phenomenon has been described at the gene level (31) . Consistent with these data, we find that reactivation of genes in somatic cell hybrids at six different loci is associated with an advancement in replication time, often to that of the normal, active X gene.
*To whom correspondence should be addressed Exceptions to this general correlation were also found, however. We observed that XIST, the gene that appears to play a major role in the establishment of X chromosome inactivation (36) , can also be induced to replicate earlier by treatment of the inactive X with 5aC even though this is the expressed allele (37,38) whose promoter region is unmethylated (39) (40) (41) (42) . Although the factor IX gene (F9) lacks a 5′ CpG island (43) and is not expressed in fibroblasts, an advance in replication time can also occur for this gene following 5aC exposure. In addition, a few cases were found of partially-advanced replication time without associated reactivation for genes capable of reactivation, including one example where the promoter is known to be fully methylated. In the latter case, the rate of 5aC-induced reactivation of HPRT is much higher than in cells with normal, later replication. These data suggest that reactivation of X-inactivated genes that are widely-expressed involves a demethylation-induced alteration of at least two control elements: the promoter and a replication time control locus, both of which must be altered to bring about reactivation.
RESULTS
To better understand the relationship of transcription to replication timing on the active and inactive X chromosomes, we have studied the replication of eight X-linked genes (XIST, XPCT, PGK1, HPRT, F9, FMR1, IDS, and G6PD) in normal cells (fibroblasts and lymphocytes), lymphoblastoid cells, and human-hamster somatic cell hybrids containing either an active or an inactive human X chromosome. For each of these genes, the active X allele replicates earlier in the cell cycle than the inactive X allele in all cell types examined. Except for F9, which is not expressed in these cell types (see Materials and Methods section), and XIST, which is expressed on the inactive X and not the active X, this means that the expressed alleles replicate before the repressed ones.
Replication time is advanced for inactive X-linked genes reactivated by 5aC treatment
To study replication timing for reactivated inactive X-linked genes, a human-hamster somatic cell hybrid with an inactive human X chromosome (X8-6T2S1) was treated with 5aC, transferred to medium selective for cells with reactivated HPRT, and the resultant clones were isolated and expanded for further study (18, 44) . We have shown previously that the promoter region of PGK1 in X8-6T2S1 is heavily methylated and that 5aC-derived clones with reactivated PGK1, including those described below, are all extensively demethylated in this region (18, 19) . The 5′ CpG island of HPRT is also heavily methylated in X8-6T2S1 (17) and several of the reactivant clones were found to be unmethylated at HpaII and HhaI restriction sites in the promoter region (R. S. Hansen, unpublished observations).
To determine if and to what extent coreactivation of HPRT and other unselected genes had occurred, RNA from such clones was analyzed by semiquantitative reverse transcriptase-PCR (RT-PCR). Transcript levels in the 5aC-treated hybrids are compared to those of an active X hybrid (GM06318). A summary of the reactivation status of six genes with 5′ CpG islands (XPCT, PGK1, HPRT, FMR1, IDS, and G6PD) is shown in Table 1 for seven selected hybrids. Reactivation of HPRT was found in all treated hybrids, as expected from their growth in HPRT-selective media. Including these instances of HPRT reactivation, 25 cases of reactivation were identified among this set of 5aC-treated hybrids. Replication timing was examined for 22 of these cases and, in all except three cases of HPRT reactivation, a significant advance in replication time relative to the parental inactive X allele was observed.
Representative replication profiles for reactivated genes are shown in Figure 1 ; replication profiles for active X and the parental inactive X alleles are presented for comparison. Replication of those genes that are strongly reactivated usually occurs at a time in S that is similar to that of the corresponding active X allele. The replication profiles of HPRT in III-5, III-14S7, and V-6CS1 were exceptional in that, despite reactivation of the gene, replication was not advanced relative to X8-6T2S1, the untreated inactive X hybrid (data not shown). It appears, however, that replication of HPRT in X8-6T2S1 is advanced relative to a normal inactive X allele to a time that is compatible with expression (see below). 1 RNA content in first strand (RT) reactions was normalized to that of the X a sample (GM06318) using MIC2 RT-PCR products (see Materials and Methods section). Extent of reactivation is indicated relative to gene expression in GM06318: <3% (-), 3-20% (+), 20-40% (++), >40% (+++); no activity was detected for these genes in X8-6T2S1, the parental hybrid with an untreated inactive X chromosome (X i ).
Partially reactivated clones and some nonreactivants exhibit advanced replication time XIST differs from the other genes studied in that it is expressed exclusively on the inactive X chromosome and it is expressed in X8-6T2S1 cells before 5aC treatment at levels similar to those in normal female fibroblasts (30) . In fibroblasts and in X8-6T2S1, we found that the inactive X allele of XIST replicates in the latter portion of S and the active X allele replicates in early S (30) . Because the promoter of the expressed, inactive X allele is unmethylated in normal human cells (40) as well as X8-6T2S1 (data not shown), we wondered if the late replication of XIST in this cell line could be altered by demethylation at some other locus. Examination of our 5aC-treated hybrid clones of X8-6T2S1 revealed a clear advance in the time of XIST replication in the 19AS2 clone ( Fig. 2A) . Although the replication time of XIST in 19AS2 is similar to that of active X alleles, no reduction in XIST expression is apparent in this cell line as determined by semiquantitative RT-PCR analyses (data not shown). These data indicate that the time of XIST replication is controlled by methylation at a site other than the promoter and is independent of transcription. In addition, the continued expression of XIST in 19AS2 and other 5aC-treated hybrids (R. S. Hansen, unpublished observations) indicates that XIST expression is not sufficient to repress those genes reactivated in these cells (Table 1 ). F9 also differs from the other genes studied in that it is a tissue-specific gene not expressed in fibroblasts and its 5′ region, which is deficient in CpG dinucleotides (43) , has a similar pattern of methylation in male and female fibroblasts (45) . We and others, however, have previously observed that F9 replicates earlier on the active X chromosome than on the inactive X in fibroblasts (30) or fibroblast-derived mouse-human hybrids (31) . It was of interest, therefore, to determine if methylation has a transcription-independent role in the replication timing of F9 on the inactive X chromosome by examining our 5aC-treated inactive X hybrids for alterations in replication timing. We found that the time of F9 replication in one 5aC-treated clone, 19AS2, was advanced to that of an active X allele (Fig. 2B) . F9 reactivation was not observed in this hybrid (described in Materials and Methods section), as expected from the probable absence of appropriate tissue-specific transcription factors and from the observation that F9 is not expressed in active X hybrids. Thus, the 5aC-induced advance in F9 replication suggests that the control of replication time on the inactive X is methylation-dependent and transcription-independent with respect to this gene.
The observation that F9 replication could be advanced by 5aC treatment suggested that advanced replication timing might also be observed for other genes in weak or nonreactivated 5aC-treated hybrids. PGK1 reactivation in one clone, VI-1C1, was only about 5% the activity of active X alleles as determined by RT-PCR analysis [although PGK1 enzymatic activity was not detected (18) ]. The replication profile for PGK1 in VI-1C1 was not as advanced as in more fully reactivated clones, exhibiting a replication peak around S3 as compared to S2 for the more reactivated clones (Fig. 2C ). Similar to these examples of advanced PGK1 replication, partial advances in replication time were observed for XPCT in some 5aC-treated clones (compared to active X alleles; 
Advanced replication timing of HPRT and G6PD in inactive X hybrids is associated with increased reactivation frequency
Reactivation of inactive X alleles of HPRT or G6PD has not been observed in normal human fibroblasts treated with 5aC (15, 46) , and the frequency of reactivation in somatic cell hybrids varies considerably (10) (11) (12) 47, 48) . If replication timing has a significant influence on the rate of reactivation of these genes, the variable rate of reactivation among the different cell lines or strains could be derived from differences in replication time. In the fibroblast-derived inactive X hybrid, X8-6T2S1, both HPRT and G6PD are inactive and their replication is retarded relative to the corresponding genes in active X hybrids ( Fig. 1A and B) . However, in contrast to the replication patterns of other tested genes in X8-6T2S1 that appear to be like those of the normal inactive X alleles (Fig. 1, Fig. 3 , and data not shown), HPRT and G6PD replication in X8-6T2S1 is advanced compared to their counterparts in normal female fibroblasts (Fig. 3) . Advanced replication is also seen for the inactive HPRT gene in 8121-TGRD, another somatic cell hybrid with an inactive X chromosome (in which G6PD is deleted). In this case, the replication pattern of the inactive HPRT gene is intermediate between the inactive gene in normal fibroblasts and that of the HPRT gene in X8-6T2S1 (Fig. 3) . Although the HPRT promoter is extensively methylated in both of these hybrids (17) , HPRT reactivation frequencies following 5aC treatment differed markedly between them: 3.4% HAT resistance for X8-6T2S1 clones and 0.46% for 8121-TGRD clones. The more advanced replication timing in X8-6T2S1 may, therefore, determine a more permissive chromosomal state with respect to reactivation. The high frequency of G6PD reactivation in X8-6T2S1 (48) suggests that advanced replication time also provides a more permissive state for reactivation of this gene.
DISCUSSION
Presented here are replication and transcription data for eight X-linked loci (XIST, XPCT, PGK1, HPRT, F9, FMR1, IDS, and G6PD). Strong reactivation of expression was associated with advanced time of replication in the cell cycle, as expected from the general finding that a gene replicates earlier in an expressing cell than in a nonexpressing cell. Among the more striking of our observations is that a reactivation-associated replication time advance is not always to the time of the active X gene and that a significant advance in time of replication can occur without reactivation. The latter observation is especially significant because it reveals the existence of previously unsuspected features regarding replication timing control and expression of X-linked genes.
The 5aC-induced advance in XIST replication time ( Fig. 2A ) indicates that the control of replication time for a gene can be independent of transcription and promoter methylation as these properties were not affected by treatment. This conclusion is supported by the observation of advanced replication time for F9 following 5aC treatment (Fig. 2B ) because (i) F9 is not expressed in fibroblasts, (ii) its promoter is deficient in CpG dinucleotides, and (iii) no obvious sex-specific differences in methylation have been found in the vicinity of the promoter either in fibroblasts or in liver, a F9-expressing tissue (45) .
Furthermore, replication timing for HPRT is not primarily controlled by promoter methylation or transcription factor binding because advanced replication of the gene in the nonexpressing X8-6T2S1 hybrid relative to a normal inactive X allele (Fig. 3A) is not associated with any change in these parameters (17, 49) . Consistent with this view is our previous finding that inactive X 'alleles' of HPRT and G6PD with advanced replication time are reactivated at high frequency in X8-6T2S1 (48) . That such an advanced state of replication is more permissive to reactivation is supported by our report here that replication of HPRT in three 5aC-treated reactivant clones (III-5, III-14S7, and V-6CS1) was not advanced relative to replication in X8-6T2S1 (data not shown).
XIST expression is required for the establishment of X chromosome inactivation (36) , but the function of the XIST gene product, a processed RNA, has not been established in somatic cells. Although XIST is ubiquitously expressed in female somatic cells, this expression is apparently not required for the maintenance of X inactivation because such repression is retained in cells with XIST deletions (50, 51) . These data do not exclude a role for XIST in the maintenance of X inactivation, however, because repression in cells lacking XIST is probably mediated by promoter methylation and/or other X inactivation mechanisms such as late replication. Our study of XIST argues against a role in the maintenance of X inactivation because 5aC-induced reactivation of several genes can occur in cells with normal levels of XIST; XIST expression, therefore, is not sufficient to maintain X inactivation in somatic cells.
In addition to our finding that the expressed allele of XIST and the repressed allele of F9 became earlier replicating after 5aC treatment, observations of advanced replication time following 5aC exposure have been reported for several nontranscribed loci, such as those containing satellite sequences (52) . These data, and our other observations of advanced replication time following 5aC exposure, suggest that replication control loci are influenced by cytosine methylation at nonpromoter sites. The earlier replication of HPRT and G6PD in the X8-6T2S1 hybrid compared to normal inactive X alleles is expected to derive from demethylation events that occurred during cell fusion or subsequent cell culture.
We propose that the effect of 5aC on the timing of replication initiation involves demethylation of a defined control region at the affected locus, similar to the requirement of promoter demethylation for transcriptional activation. Alternatively, trans acting factors that influence replication timing might be activated by 5aC. Such factors would be expected to have pleiotropic effects, however, and none were observed in our 5aC-treated hybrid clones because they differed from each other in the number and identity of loci with advanced replication time.
One candidate locus in which methylation could directly affect the timing of replication is the region of replication initiation itself. Although mammalian replication can initiate in large zones, the preferred sites of initiation are more limited (53, 54) . The time in S phase when a replicon begins replication may depend on methylation of sites in the region of preferred initiation or methylation of a greater number of sites in the larger zone of initiation. Cytosine methylation has recently been reported for two mammalian replication origins (55), but its relevance to the stable transmission of replication timing information to daughter cells is unclear because it is not restricted to CpG sites and is only present in a limited stage of the cell cycle.
Locus control regions (LCRs) are also candidate regions for methylation control of replication time. X-linked loci of this type may have a primary role in the establishment and maintenance of X chromosome inactivation (56, 57) . The globin LCR, whose activity is altered by tissue-specific modifications, is known to affect the timing of origin activity (58, 59) and is apparently required for normal origin function (60) even though it is located 50 kb away from that locus. Although X-linked LCRs have yet to be identified, methylation of such regions could, therefore, have a regulatory influence on replication initiation at distant origins.
Thus, we propose that a high level of methylation at replication origins, LCRs, or other yet-unidentified replication control regions on the inactive X chromosome results in late replicating, heterochromatic regions and that the corresponding loci on the active X chromosome are unmethylated. The unmethylated state of the active X loci leads to an advanced replication state, but not necessarily to a transcriptionally active one. Transcription within the replicon would require additional conditions; the primary condition for housekeeping genes with a 5′ CpG island, such as those studied here, is an unmethylated promoter. Even under conditions of induced demethylation, therefore, reactivation of an inactive X-linked gene in normal cells would be unlikely because demethylation of several sites would be required in both the replication control region and the promoter.
Partial or full demethylation of the replication control region would bring about an advance in replication time and a permissive state in which reactivation could occur at a much higher frequency because only promoter demethylation is required. A compelling argument for the permissive effect of earlier replication can be invoked from the reactivation rates for the HPRT gene in two different hybrid cell lines containing an inactive human X chromosome (X8-6T2S1 and 8121-TGRD). The replication time shift of HPRT in X8-6T2S1 is more advanced than that of HPRT in 8121-TGRD (Fig. 3) , and, as expected from the above hypothesis, the reactivation rate for X8-6T2S1 is an order of magnitude greater than that for 8121-TGRD. The inactive X in 8121-TGRD is not uniformly later than in X8-6T2S1 because PGK1 replicates earlier in 8121-TGRD than in X8-6T2S1 (Fig. 3) . The lower frequency of PGK1 reactivation in X8-6T2S1 relative to HPRT (R. S. Hansen, unpublished RT-PCR data) may reflect the more normal replication timing of PGK1 in these cells (Fig. 3) . These observations allow us to suggest that the wide variability in reactivation frequency reported for HPRT, G6PD, PGK1, and other X-inactivated genes in different hybrid cell lines (10) (11) (12) 47, 48) could be explained in large part by differences between hybrids in the extent to which replication time has advanced for each gene.
A recent study of 5-methyl dCTP-and 5aC-induced alterations in HPRT expression provides an example of 5aC-induced reactivation in normal male fibroblasts (61) . In this study, a high frequency of gene inactivation was observed following the introduction of 5-methyl dCTP into cells by electroporation, presumably because of increased methylation. Consistent with this view is their observation that reactivation of HPRT in such cultures could be induced by treatment with 5aC. Although no molecular or clonal analysis was carried out, this study appears to be the first example of 5aC-induced reactivation in a normal human fibroblast. As this is not a case of reversing X inactivation, the relatively high frequency of gene reactivation could be explained by our model of multiple, methylation-sensitive transcriptional control loci. It is likely that the 5-methyl dCTP-induced inactivation of the active X allele of HPRT occurred by methylation of only one methylation-sensitive control locus (the promoter or the replication time control locus) and the gene would, therefore, be in a more permissive state for reactivation by 5aC than would a normal inactive X allele.
Increased reactivation in somatic cell hybrids could also result from perturbation of additional elements that control the expression of an X-inactivated gene. Such an element might be a histone acetylation control mechanism because, in addition to promoter methylation and replication timing, histone acetylation also distinguishes the active and inactive X chromosomes (62) . Differences in the extent to which general and locus-specific X inactivation control elements are perturbed in inactive X hybrids may explain more fully the observation (noted above) that such hybrids have different reactivation rates for the same gene.
Whether a methylation-sensitive control locus for replication timing is at the replication origin or at a more distant site, comparative restriction mapping with methyl-sensitive endonucleases between hybrids with shifted and unshifted alleles may reveal promising candidate regions for replication control.
Candidate regions could then be tested for function as replication initiation sites and for properties of an LCR.
MATERIALS AND METHODS

Cell culture and flow cytometry
Standard growth conditions for cultured cells were as previously described (44) . CHO-YH21 is a Chinese hamster ovary cell line (63) . X8-6T2S1 is a 6-thioguanine-resistant human-hamster hybrid cell subclone that contains a single, human inactive X chromosome derived from a human fibroblast; Y162-11CS3 is a similarly derived hybrid that contains an active X chromosome (18, 21, 44, 63) .
Hypoxanthine, aminopterin, thymidine (HAT)-resistant hybrid clones derived from X8-6T2 cells were described previously or similarly derived by 5aC treatment (18, 44) . GM06318 was obtained from the NIGMS Human Genetic Mutant Cell Repository and is a human fibroblasthamster hybrid cell line that contains a single, active human X chromosome. 8121-TGRD is a human-hamster hybrid containing an inactive human X chromosome that is terminally-deleted distal to Xq26 (17, 64) . X8-6T2S1 and 8121-TGRD reactivation rates for HPRT were determined simultaneously by treating cells in log-phase growth with 5aC (44) and then selecting HPRT-positive clones with HAT medium after only 24 hours. Reactivation frequency was determined by counting the number of colonies that arose in plates with HAT medium in comparison to those with normal medium as described previously (44) . HeLa cells were cultured in RPMI 1640 with 15% fetal bovine serum. This medium was also used to culture mitogen-stimulated peripheral lymphocytes from a normal female (194 female). Normal human fibroblasts (such as the female strain 78-18) were obtained as frozen stocks of early-passage strains from G. Martin (Department of Pathology, University of Washington) and grown in Chang's Medium (Irvine Scientific). Cells were labeled with 5-bromo-2′-deoxyuridine (BrdU) and processed for flow cytometry as previously described (29, 30) . BrdU-labeled cells were separated into different phases of the cell cycle on an EPICS Elite cell sorter and BrdU-containing DNA (BrdU-DNA) was isolated from these cells by antibody precipitation as described previously (29) . BrdU-labeled CHO-YH21 DNA was added to sorted human cells and BrdU-labeled Drosophila DNA was added to sorted human-hamster hybrid cells to provide controls for recovery and amplification of newly-replicated BrdU-DNA (29, 30) .
PCR analysis of replicated DNA
Replication timing for human genes was determined using sequence tagged site (STS) primer sets described in Table 2 . Hamster (28S and Aprt genes) or Drosophila (Gbe gene) STSs used to analyze added control BrdU-DNA were described previously (29, 30) . All PCR reactions contained 2.5 U AmpliTaq (Perkin Elmer Cetus) and a portion of antibody-purified BrdU-DNA corresponding to 1000 sorted cells in 100 µl standard reaction buffer (Perkin Elmer Cetus). Reactions were started from ice by placing in a water-cooled thermocycler (Ericomp) maintained at the denaturation temperature (94_C or 95_C). PCR parameters have previously been described for several of the STSs listed in Table 2 (29, 30) . Additional reaction conditions are as follows: idsE:idsD, 95_C 5 min, 25 cycles of 95_C 30 s, 60_C 30 s, 72_C 2 min, final extension at 72_C for 7 min; pgkix:pgkixr, 95_C 5 min, 27 cycles of 95_C 1 min, 60_C 1 min, 72_C 2 min, final extension at 72_C for 7 min; xpct675U:xpct928L, 95_C 5 min, 25 cycles of 95_C 1 min, 65_C 1 min, 75_C 2 min, final extension at 75_C for 7 min; dxs128-1:dxs128-2, 94_C 5 min, 25 cycles of 94_C 1 min, 58_C 1 min, 72_C 2 min, final extension at 72_C for 7 min.
Agarose gel electrophoresis of PCR products, Southern transfer, probe isolation, probe labeling, hybridization conditions, and membrane washing procedures were as previously described (21, 29) . Quantitation of hybridization signals was performed by PhosphorImager analysis (Molecular Dynamics; PhosphorImager Analysis Facility of the Markey Molecular Medicine Center at the University of Washington). Replication of a sequence in a particular cytometry fraction is expressed as a percentage of the sum of that in all fractions.
Prior to anti-BrdU antibody purification, BrdU-DNA from certain replication profiles was digested with either HpaII or SacII as previously described (30, 33 ). BrdU-DNA was then isolated by antibody precipitation.
RT-PCR analysis
Total RNA was isolated by the acid guanidinium thiocyanate method (16, 65) . First strand synthesis of cDNA was generated with random hexamers as previously described (16) from 0.25, 0.50, and 1.0 µg RNA. Control reactions that contained no reverse transcriptase were performed with 0.5 µg RNA. Ten percent of the cDNA product was used for PCR amplification using the standard reaction constituents described for amplification of BrdU-DNA. Amplification of cDNA was performed using the following primer sets: XIST, xst30:29r (30) or xst8:9r [sequences in Figure 2 of reference (50) (16) . PCR parameters were similar to those previously published [see references above and (30)], limiting amplification to between 18 and 21 cycles so as to remain in an exponential range. Fifteen percent of the PCR product was subject to gel electrophoresis, Southern analysis, and PhosphorImager quantification. Hybridization per ng of input RNA was calculated and averaged for PCR products obtained from 0.5 and 1.0 µg RT samples and these values were normalized for cDNA recovery and amplification potential assuming equal expression of MIC2 among the various hybrids (normalization factors were obtained from values for XMIC:XMIC2R products derived from the same RT reactions). RT-PCR analysis of F9 expression in somatic cell hybrids and in human liver was performed similarly, using 0.2 µM exon 4:exon 8 primers (IX-7, 5′-ttaaatggcggcagttgca-3′ and chen-110, 5′-gaataattcgaatcacatt-3′; sequences derived from HUMFIX, Genbank no. J00136). One quarter of the RT product (derived from 0.125 or 0.25 µg RNA) was amplified under the following conditions: 94_C 5 min, 40 cycles of 94_C 1 min, 50_C 1 min, 72_C 2 min, final extension at 72_C for 7 min. The PCR reactions were analyzed by agarose electrophoresis and ethidium bromide staining. Liver RNAs were positive for the 600 bp F9 band, whereas this product was not observed from hybrids with an active or inactive X chromosome, or from inactive X hybrid clones such as 19AS2 that had been treated with 5aC.
